Instead, Ozempic works primarily by reducing appetite, slowing gastric emptying, and enhancing insulin secretion in a glucose-dependent manner
Pen-sharing poses a risk for transmission of blood-borne pathogens Adverse Reactions Most common adverse reactions (incidence 5%) are: nausea, diarrhea, vomiting, constipation, abdominal pain, dysesthesia, headache, fatigue, dyspepsia, dizziness, abdominal distention, eructation, hypoglycemia in patients with T2D, flatulence, gastroenteritis, gastroesophageal reflux disease, and hair loss Drug Interactions When initiating Wegovy , consider reducing the dose of concomitantly administered insulin secretagogues or insulin to reduce the risk of hypoglycemia
Recent advancements in drug treatment of obesity (in Eng)
The medial temporal lobe
Donnelly is a highly experienced physician with over 30 years in the medical field, specializing in emergency medicine and Osteopathic Medicine
The first Phase III readout from the TRIUMPH-5 study in obesity is expected in late 2026